Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Autosomal recessive progeroid syndrome due to homozygosity for a TOMM7 variant
Abhimanyu Garg, … , Anil K. Agarwal, Prashant Mishra
Abhimanyu Garg, … , Anil K. Agarwal, Prashant Mishra
Published October 25, 2022
Citation Information: J Clin Invest. 2022;132(23):e156864. https://doi.org/10.1172/JCI156864.
View: Text | PDF
Concise Communication Endocrinology Genetics

Autosomal recessive progeroid syndrome due to homozygosity for a TOMM7 variant

  • Text
  • PDF
Abstract

Multiple genetic loci have been reported for progeroid syndromes. However, the molecular defects in some extremely rare forms of progeria have yet to be elucidated. Here, we report a 21-year-old man of Chinese ancestry who has an autosomal recessive form of progeria, characterized by severe dwarfism, mandibular hypoplasia, hyperopia, and partial lipodystrophy. Analyses of exome sequencing data from the entire family revealed only 1 rare homozygous missense variant (c.86C>T; p.Pro29Leu) in TOMM7 in the proband, while the parents and 2 unaffected siblings were heterozygous for the variant. TOMM7, a nuclear gene, encodes a translocase in the outer mitochondrial membrane. The TOMM complex makes up the outer membrane pore, which is responsible for importing many preproteins into the mitochondria. A proteomic comparison of mitochondria from control and proband-derived cultured fibroblasts revealed an increase in abundance of several proteins involved in oxidative phosphorylation, as well as a reduction in abundance of proteins involved in phospholipid metabolism. We also observed elevated basal and maximal oxygen consumption rates in the fibroblasts from the proband as compared with control fibroblasts. We concluded that altered mitochondrial protein import due to biallelic loss-of-function TOMM7 can cause severe growth retardation and progeroid features.

Authors

Abhimanyu Garg, Wee-Teik Keng, Zhenkang Chen, Adwait Amod Sathe, Chao Xing, Pavithira Devi Kailasam, Yanqiu Shao, Nicholas P. Lesner, Claire B. Llamas, Anil K. Agarwal, Prashant Mishra

×

Figure 3

The functional impact of TOMM7 variant, P29L.

Options: View larger image (or click on image) Download as PowerPoint
The functional impact of TOMM7 variant, P29L.
(A) Immunoprecipitation of...
(A) Immunoprecipitation of FLAG-TOMM7WT (WT), FLAG-TOMM7P29L (P29L), or empty vector transiently expressed in HEK293 cells, as assessed by Western blot. Input whole cell lysates and immunoprecipitated fractions (IP FLAG) are shown. TOMM7P29L displays decreased interaction with the core TOMM complex (TOMM40 and TOMM22). Molecular weights are indicated. (B) Similar to A, but in Tomm7–/– HeLa cells transduced with TOMM7wt or Tomm7P29L-expressing lentiviral particles. (C) Heterologous expression of TOMM7WT (wildtype) or TOMM7P29L (tagged with GFP [green]) in Tomm7–/– HeLa cells indicates both proteins are localized to mitochondria; mitochondria visualized with anti-TOMM40 (red). (D) Increased basal and maximal (uncoupled) oxygen consumption rates (OCR) measured in proband (TOMM7P29L) and control fibroblast cell lines. n = 11–16 for each cell line. A linear mixed model (GraphPad Prism) was fit to test the difference between proband and control cell lines. Box plots indicate median and interquartile values; whiskers are plotted using the Tukey method. (E) Volcano plot of mitochondrial ETC component protein abundance in proband versus control fibroblasts. Individual proteins are color-coded based on the mitochondrial complex with which they are associated. (F) GSEA of mitochondrial ETC components in proband and control cell lines. The normalized enrichment score (NES) and P value are indicated. (G) Western blot analysis of TOMM7 and candidate mitochondrial ETC proteins in proband and control cell lines. Molecular weights are indicated. Actin and HSP60 levels are shown as loading controls.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts